Cleidocranial dysostosis is an uncommon genetic disorder characterized by anomalies in bone development, particularly impacting the collarbones and skull. This condition results from mutations in the RUNX2 gene, disrupting proper bone formation and ossification. Individuals with cleidocranial dysostosis often present with distinctive physical traits, including the absence or underdevelopment of collarbones, delayed closure of fontanelles (soft spots) in the skull, and dental irregularities such as delayed eruption of adult teeth and the presence of extra teeth.
Beyond affecting the skeletal system, cleidocranial dysostosis influences facial structure and dental health. Challenges in speech and motor development may arise, accompanied by difficulties in fine and gross motor skills. The management of cleidocranial dysostosis necessitates a multidisciplinary approach, integrating orthopedic care, dental interventions, and speech therapy. Timely monitoring and early interventions are critical to addressing the specific challenges associated with this genetic disorder.
Despite the intricacies of cleidocranial dysostosis, ongoing advancements in medical knowledge and treatment options contribute to enhanced outcomes. Support groups and patient advocacy efforts play a pivotal role in providing valuable information and fostering a supportive community for individuals and families affected by this genetic condition. In essence, cleidocranial dysostosis highlights the intricate relationship between genetics and bone development, emphasizing the need for holistic care to address its diverse manifestations and improve the overall well-being of individuals grappling with this condition.
Title : Prevention in medicine, especially in the field of dentistry in the Netherlands
Jaap Boehmer, Rijnstate Hospital Arnhem, Netherlands
Title : Principles of facial trauma surgery 2026
Steven J Traub, American Institute of Oral Biology, United States
Title : Personalized and Precision Medicine (PPM) as a transformative healthcare model via biodesign inspired translational applications to secure human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Occlusion and implants
Christopher Turner, Spacemark Dental, United Kingdom
Title : Cleft lip and palate management: Multidisciplinary approach
Theresa P Chiang, Canada-China Child Health Foundation, Canada
Title : Bilateral reconstruction of the midface (Le Fort I/II) with microvascularized fibular flap: A proposed new technique
Laurindo Moacir Sassi, Erasto Gaertner Hospital Cancer Center and Mackenzie Evangelical University Hospital, Brazil